ProCE Banner Activity

Practical Guidance on Individualized Patient Care Strategies for Myelodysplastic Syndromes

Slideset Download
Download these expert-selected slides on myelodysplastic syndromes to help diagnose and manage your patients with MDS.

Released: January 12, 2022

Expiration: January 11, 2023

No longer available for credit.

Share

Faculty

Amy E. DeZern

Amy E. DeZern, MD, MHS

Associate Professor
Oncology and Medicine
The Johns Hopkins University School of Medicine
Baltimore, Maryland

Rami S. Komrokji

Rami S. Komrokji, MD

Professor of Oncologic Sciences
Department of Oncologic Sciences
University of Florida
Senior Member/Clinical Director
Malignant Hematology
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Bristol Myers Squibb

Karyopharm Therapeutics

Taiho Oncology

Faculty Disclosure

Primary Author

Amy E. DeZern, MD, MHS

Associate Professor
Oncology and Medicine
The Johns Hopkins University School of Medicine
Baltimore, Maryland

Amy E. DeZern, MD, MHS, has disclosed that she has received consulting fees from Bristol-Myers Squibb, Jasper, Novartis, Taiho, and Takeda.

Rami S. Komrokji, MD

Professor of Oncologic Sciences
Department of Oncologic Sciences
University of Florida
Senior Member/Clinical Director
Malignant Hematology
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida

Rami S. Komrokji, MD, has disclosed that he has received consulting fees from AbbVie, Acceleron, Agios/Servier, Bristol-Myers Squibb/Celgene, Geron, Jazz, and Novartis, PharmaEssentia, and Taiho.